Active ingredient
Angiotensin Ii
3 finished FDA listings contain Angiotensin Ii as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ANGIOTENSIN II, ANGIOTENSIN II ACETATE
- Dosage forms
- Injection
- Routes
- Intravenous
- Manufacturers / labelers
- 2
- Strengths listed
- .5 mg/ml · 2.5 mg/ml
- Brand names in FDA listings
- Giapreza
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1999003
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 209360 | LA JOLLA PHARMA | 2017-12-21 | 2 |
| ANDA 216966 | GLAND | 2025-06-03 | 1 |
Official labeling on DailyMed
- GIAPREZA (ANGIOTENSIN II) INJECTION [LA JOLLA PHARMACEUTICAL COMPANY] · version 18 · 2026-07-24
- ANGIOTENSIN II INJECTION [GLAND PHARMA LIMITED] · version 3 · 2025-06-05
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.